Mesenchymal Stem Cell Therapy in Acute Liver Failure

Overview

Journal Gut Liver

Specialty Gastroenterology

Date 2023 Feb 27

PMID 36843422

Authors

Yong-Hong Wang

En-Qiang Chen

Affiliations

Soon will be listed here.

Abstract

Acute liver failure (ALF) is a severe liver disease syndrome with rapid deterioration and high mortality. Liver transplantation is the most effective treatment, but the lack of donor livers and the high cost of transplantation limit its broad application. In recent years, there has been no breakthrough in the treatment of ALF, and the application of stem cells in the treatment of ALF is a crucial research field. Mesenchymal stem cells (MSCs) are widely used in disease treatment research due to their abundant sources, low immunogenicity, and no ethical restrictions. Although MSCs are effective for treating ALF, the application of MSCs to ALF needs to be further studied and optimized. In this review, we discuss the potential mechanisms of MSCs therapy for ALF, summarize some methods to enhance the efficacy of MSCs, and explore optimal approaches for MSC transplantation.

Citing Articles

Application of mesenchymal stem cells in liver fibrosis and regeneration.

Liu Z, Ren J, Qiu C, Wang Y, Zhang T Liver Res. 2025; 8(4):246-258.

PMID: 39958916 PMC: 11771278. DOI: 10.1016/j.livres.2024.11.004.

Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure.

Lu Y, Chen T, Lin H, Chen Y, Lin Y, Le D J Extracell Vesicles. 2025; 14(2):e70044.

PMID: 39901768 PMC: 11791321. DOI: 10.1002/jev2.70044.

Ethical frontiers in liver transplantation.

Wong H, Selvakumar S, Loh P, Liau J, Liau M, Shelat V World J Transplant. 2024; 14(4):96687.

PMID: 39697458 PMC: 11438941. DOI: 10.5500/wjt.v14.i4.96687.

Use of Mesenchymal Stem Cell Transplantation as a Treatment for Liver Cirrhosis in Animal Models.

Skuratov A, Osipov B, Lyzikov A, Zinovkin D, Adam I, Kaplan M Cureus. 2024; 16(10):e71720.

PMID: 39553019 PMC: 11568846. DOI: 10.7759/cureus.71720.

Cellular Plasticity in Gut and Liver Regeneration.

Kim M, Park Y, Kim Y, Ko S Gut Liver. 2024; 18(6):949-960.

PMID: 39081200 PMC: 11565004. DOI: 10.5009/gnl240005.

References

Zhao S, Liu Y, Pu Z . Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro. Drug Des Devel Ther. 2019; 13:2887-2897. PMC: 6707369. DOI: 10.2147/DDDT.S220190. View

Zheng Y, Zhu S, Zheng X, Xu W, Li X, Li J . Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells. J Clin Transl Hepatol. 2021; 9(4):503-513. PMC: 8369013. DOI: 10.14218/JCTH.2021.00014. View

Manzini B, Duarte A, Sankaramanivel S, Ramos A, Latuf-Filho P, Escanhoela C . Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis. Cytotherapy. 2015; 17(8):1052-65. DOI: 10.1016/j.jcyt.2015.04.010. View

Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng S . Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine. Front Pharmacol. 2021; 11:590470. PMC: 7944140. DOI: 10.3389/fphar.2020.590470. View

Deng C, Qin A, Zhao W, Feng T, Shi C, Liu T . Up-regulation of CXCR4 in rat umbilical mesenchymal stem cells induced by serum from rat with acute liver failure promotes stem cells migration to injured liver tissue. Mol Cell Biochem. 2014; 396(1-2):107-16. DOI: 10.1007/s11010-014-2147-7. View

Wang Y, Wang J, Ma H, Tang Z, Ding H, Shi X . Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure. Biochem Biophys Res Commun. 2018; 508(3):682-689. DOI: 10.1016/j.bbrc.2018.11.146. View

Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M . Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells. 2014; 32(11):2818-23. DOI: 10.1002/stem.1818. View

Tao X, Li W, Su J, Jin C, Wang X, Li J . Clonal mesenchymal stem cells derived from human bone marrow can differentiate into hepatocyte-like cells in injured livers of SCID mice. J Cell Biochem. 2009; 108(3):693-704. DOI: 10.1002/jcb.22306. View

van Poll D, Parekkadan B, Cho C, Berthiaume F, Nahmias Y, Tilles A . Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008; 47(5):1634-43. DOI: 10.1002/hep.22236. View

10.

Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D . Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016; 14:45. PMC: 4746907. DOI: 10.1186/s12967-016-0792-1. View

11.

Cai W, Huang Q, Gu Y, Shi Y, Huang J, Zhao F . Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology. 2013; 59(2):671-82. PMC: 4298763. DOI: 10.1002/hep.26670. View

12.

Zheng S, Yang J, Yang J, Tang Y, Shao Q, Guo L . Transplantation of umbilical cord mesenchymal stem cells via different routes in rats with acute liver failure. Int J Clin Exp Pathol. 2016; 8(12):15854-62. PMC: 4730069. View

13.

Wang P, Cui Y, Wang J, Liu D, Tian Y, Liu K . Mesenchymal stem cells protect against acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor. Stem Cell Res Ther. 2022; 13(1):94. PMC: 8895877. DOI: 10.1186/s13287-022-02754-x. View

14.

Zhu X, He B, Zhou X, Ren J . Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res. 2012; 351(3):477-86. DOI: 10.1007/s00441-012-1524-3. View

15.

Yang J, Cao H, Pan Q, Yu J, Li J, Li L . Mesenchymal stem cells from the human umbilical cord ameliorate fulminant hepatic failure and increase survival in mice. Hepatobiliary Pancreat Dis Int. 2015; 14(2):186-93. DOI: 10.1016/s1499-3872(15)60354-x. View

16.

Hu C, Zhao L, Zhang L, Bao Q, Li L . Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020; 11(1):377. PMC: 7469278. DOI: 10.1186/s13287-020-01895-1. View

17.

Parekkadan B, van Poll D, Suganuma K, Carter E, Berthiaume F, Tilles A . Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One. 2007; 2(9):e941. PMC: 1978513. DOI: 10.1371/journal.pone.0000941. View

18.

Chae Y, Won Jun D, Lee J, Saeed W, Kang H, Jang K . The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury. Gut Liver. 2019; 13(4):450-460. PMC: 6622567. DOI: 10.5009/gnl18235. View

19.

Zhang K, Sun H, Cao H, Jia Y, Shu X, Cao H . The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis. Stem Cell Res Ther. 2021; 12(1):466. PMC: 8379867. DOI: 10.1186/s13287-021-02544-x. View

20.

Milosavljevic N, Gazdic M, Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z . Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017; 23(8):1040-1050. DOI: 10.1002/lt.24784. View